Marker Therapeutics, Inc. Stock price
Is Marker Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.
Key metrics
Marker Therapeutics, Inc. Stock Analysis
Analyst Opinions
9 Analysts have issued a Marker Therapeutics, Inc. forecast:
Analyst Opinions
9 Analysts have issued a Marker Therapeutics, Inc. forecast:
Don't miss a Thing! We will send you all news about Marker Therapeutics, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Marker Therapeutics, Inc. Stock News
Company Profile
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
| Head office | United States |
| CEO | Dr. Vera |
| Employees | 5 |
| Founded | 1991 |
| Website | markertherapeutics.com |


